These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22807964)

  • 1. Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment.
    Yang Z; Wang Z; Fan Y; Zheng Q
    Oncol Lett; 2012 Jul; 4(1):75-79. PubMed ID: 22807964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated CD133 expression in tumorigenesis of colon cancer cells.
    Yang ZL; Zheng Q; Yan J; Pan Y; Wang ZG
    World J Gastroenterol; 2011 Feb; 17(7):932-7. PubMed ID: 21412503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
    Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
    Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.
    Kim KH; Yoo BC; Kim WK; Hong JP; Kim K; Song EY; Lee JY; Cho JY; Ku JL
    Electrophoresis; 2014 Feb; 35(4):522-32. PubMed ID: 24339132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line.
    Fan X; Ouyang N; Teng H; Yao H
    Int J Colorectal Dis; 2011 Oct; 26(10):1279-85. PubMed ID: 21670985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TNF-α activates PI3K/AKT pathway to promote proliferation of SW620
    Dai L; Zhao X; Ma L; Li X; Zuo D; Li Y; Wei B; Sui Y; Xu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):33-41. PubMed ID: 32314722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line.
    Rajabi Fomeshi M; Ebrahimi M; Mowla SJ; Firouzi J; Khosravani P
    Cell J; 2016; 18(1):21-7. PubMed ID: 27054115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analyses of CD133 expression facilitate researches on tumor stem cells.
    Liao Y; Hu X; Huang X; He C
    Biol Pharm Bull; 2010; 33(5):738-42. PubMed ID: 20460748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment.
    Song YJ; Zhang SS; Guo XL; Sun K; Han ZP; Li R; Zhao QD; Deng WJ; Xie XQ; Zhang JW; Wu MC; Wei LX
    Cancer Lett; 2013 Oct; 339(1):70-81. PubMed ID: 23879969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
    Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA
    Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.
    Schneider M; Huber J; Hadaschik B; Siegers GM; Fiebig HH; Schüler J
    BMC Cancer; 2012 Mar; 12():96. PubMed ID: 22433494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity.
    Mirzaei H; Salehi H; Sahebkar A; Avan A; Jaafari MR; Namdar A; Rezaei A; Mirzaei HR
    J Res Med Sci; 2016; 21():64. PubMed ID: 27904609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of sphere-forming HCT116 clones by whole RNA sequencing.
    Chung E; Oh I; Lee KY
    Ann Surg Treat Res; 2016 Apr; 90(4):183-93. PubMed ID: 27073788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O; Wang Z; Griffin M
    Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.